Fig. 4From: Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recoveryCorrelation analysis between the cytokine level at day 30 and the days of platelet engraftmentBack to article page